{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T01:57:57Z","timestamp":1698199077461},"reference-count":44,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":7418,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1989,1]]},"abstract":"<jats:p>A low\u2010dose interferon (IFN)\u2010\u03b1 regimen for the treatment of hairy cell leukemia (HCL) was evaluated by following changes in leukocyte differentiation antigens (LDA), natural killer cell (NK) and 2\u2032,5\u2032\u2010oligoadenylate (2\u20105A) synthetase activities. Due to hairy cells' (HC) weak expression of several antigens positive for T cells, B cells, NK cells and monocytes, the use of a double marker specific for hairy cells was needed to distinguish the different subpopulations. Analysis of LDA in peripheral blood (PB) showed a total normalization of the T cell and monocyte numbers within 90 days, the number of NK cells normalized in 90 to 180 d, whereas normalization of B cell number was seen only after 180 to 360 d of treatment. Mean pretreatment 2\u20105A synthetase activity was normal or low, but upon treatment the levels rose immediately to higher than normal values and remained high throughout the study. Pretreatment NK activity was low, but normalized after between 90 to 360 d, except in 2 patients with severe splenomegaly. In vitro incubation of peripheral blood mononuclear cells (PBMNC) with IFN\u2010\u03b1 induced activation of the NK and 2\u20105A synthetase activity in untreated patients, but with treatment these effects were gradually abolished, indicating an increasing effect of IFN\u2010\u03b1 in vivo with time. These results shows that the different PBMNC subpopulations and important immunological functions normalize with treatment. This normalization is, however, not seen until at least after 1 year of treatment, indicating that the treatment schedule should be longer. As no exhaustion to the effect of IFN was seen, as measured by the 2\u20105A synthetase activity, a continuing beneficial effect of treatment is anticipated. The increasing effect of IFN\u2010\u03b1 after the first signs of clinical effect suggests that the doses used in the present study were higher than necessary.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1989.tb00247.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T02:55:59Z","timestamp":1279421759000},"page":"50-59","source":"Crossref","is-referenced-by-count":11,"title":["Immunological recovery and dose evaluation in IFN\u2010\u03b1 treatment of hairy cell leukemia: Analysis of leukocyte differentiation antigens, NK and 2\u2018,5\u2019\u2010oligoadenylate synthetase activity"],"prefix":"10.1111","volume":"42","author":[{"given":"Bendt","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Hokland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Just","family":"Justesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen","family":"Ellegaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hokland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.14.4522"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.me.30.020179.000313"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V60.3.571.571"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000206409"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/blood.V57.3.464.464","article-title":"Progress report on chlorambucil therapy in postsplenectomy patients with progressive hairy cell leukemia","volume":"57","author":"Golomb HM","year":"1985","journal-title":"Blood"},{"issue":"2","key":"e_1_2_1_7_2","first-page":"493","article-title":"Therapeutic leukophareises in HCL: a review of the literature and personal experience","volume":"11","author":"Yan LT","year":"1984","journal-title":"Semin Oncol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1182\/blood.V65.1.115.115","article-title":"Intensive chemotherapy of hairy cell leukemia in patients with aggressive disease","volume":"65","author":"Calvo F.","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198208193070805"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1200\/JCO.1984.2.12.1336","article-title":"Hairy cell leukemia: Induction of complete remission with pentostatin (2\u2010deoxyformycin)","volume":"1","author":"Spiers ASD","year":"1984","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1200\/JCO.1986.4.6.900","article-title":"Alfa\u20102 interferon therapy of hairy\u2010cell leukemia: A multicenter study of 64 patients","volume":"4","author":"Goloms HM","year":"1986","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000215641"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00207257","article-title":"The treatment of hairy cell leukemia with recombinant alfa interferon: a multi\u2010institutional study","volume":"5","author":"Thompson JA","year":"1987","journal-title":"Invest New Drugs"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb07480.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198401053100104"},{"key":"e_1_2_1_16_2","unstructured":"HasselbalchH. BraideI. LisseIM et al.Recombinant interferon\u2010alpha\u20102B treatment of hairy\u2010cell leukemia. Experience with a low dose\u2010schedule.Eur J Haemat(In press)."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1985.tb00802.x"},{"key":"e_1_2_1_18_2","first-page":"326","article-title":"Results of treating 53 hairy cell leukemia patients with \u03b1\u2010interferon","volume":"1","author":"Flandrin G.","year":"1987","journal-title":"Leukemia"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198502143120714"},{"key":"e_1_2_1_20_2","first-page":"21","volume-title":"On the recent excitement in interferon research","author":"Lingyel P.","year":"1986"},{"key":"e_1_2_1_21_2","first-page":"4848","article-title":"In vivo sensitivity and resistance of chronic myelogenous leukaemia cells to \u03b1\u2010interferon: Correlation with receptor binding and induction of 2\u20325\u2032\u2010oligoadenylate synthetase","volume":"46","author":"Rosenblum MG","year":"1986","journal-title":"Cancer Res"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1981.1.587"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111905"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000233933"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/cdd.1985.2.91"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110005"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830110412"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.4049\/jimmunol.130.6.2947","article-title":"Characterization of an antigen expressed by human natural\u2010killer cells","volume":"130","author":"Griffin JD","year":"1983","journal-title":"J Immunol"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110348"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1182\/blood.V65.4.974.974","article-title":"The monoclonal antibodies SHCL\u20101 (Leu\u201014) and SHCL\u20103 (Leu\u2010M5) allow the diagnosis of hairy cell leukemia","volume":"65","author":"Schwarting R.","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood.V70.4.1063.1063","article-title":"A two\u2010color flow cytometry assay for detection of hairy cells using monoclonal antibodies","volume":"70","author":"Kristensen JS","year":"1987","journal-title":"Blood"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990070215"},{"key":"e_1_2_1_33_2","unstructured":"HoklandM. JacobsenN. EllegaardJ. HoklandP.NK\u2010function following allogeneic bone marrow transplantation: Very early re\u2010emergence but strong dependence of cytomegalovirus infection state.Transplantation(In press)."},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/8.14.3073"},{"key":"e_1_2_1_35_2","first-page":"377","article-title":"Effect of \u03b1\u2010interferon on the immune system of patients with hairy cell leukemia","volume":"4","author":"Foa R.","year":"1987","journal-title":"Leukemia"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870615)59:12<1987::AID-CNCR2820591203>3.0.CO;2-K"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90705-9"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V61.6.1132.1132"},{"key":"e_1_2_1_39_2","first-page":"189","article-title":"Nk lymphocytosis in HCL of phenotypically identifiable cells with a defect function","volume":"13","author":"Smith BR","year":"1985","journal-title":"Act Exp Hematol"},{"key":"e_1_2_1_40_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.V68.1.293.293","article-title":"\u03b1\u2010interferon activates the natural killer system in patients with hairy cell leukemia","volume":"68","author":"Semenzato G.","year":"1986","journal-title":"Blood"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00320790"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1986.6.189"},{"key":"e_1_2_1_43_2","first-page":"439","volume-title":"The 2\u20105A synthetase System: Molecular and Clinical Aspects of the Interferon\u2010Regulated Pathway","author":"Justesen J.","year":"1985"},{"key":"e_1_2_1_44_2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jnci\/75.5.849","article-title":"NC of human blood lymphocytes and monocytes and their cytotoxic factor: Effect of interferon on target cell susceptibility","volume":"75","author":"Uchida A.","year":"1985","journal-title":"JNCI"},{"key":"e_1_2_1_45_2","first-page":"791","article-title":"R\u2010alpha\u20102 IFN in the treatment of hairy cell leukemia","volume":"69","author":"Thompson JR","year":"1985","journal-title":"Cancer Treat Rep"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1989.tb00247.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1989.tb00247.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T04:25:40Z","timestamp":1697948740000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1989.tb00247.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1989,1]]}},"alternative-id":["10.1111\/j.1600-0609.1989.tb00247.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1989.tb00247.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,1]]}}}